Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
Thyroid cancer is the most common type of endocrine malignancy.Cornerstones of thyroid cancer treatment include surgery, radioactive iodine ablation, and thyroid stimulating hormone suppression.The National Fabric Refreshers Comprehensive Cancer Network guidelines recommend two tyrosine kinase inhibitors for thyroid cancer patients who are non-resp